Article | October 12, 2022

Is Real-World Data The Real Deal?

Source: Merative

By Liisa A. Palmer, PhD, Portfolio Leader, HEOR Services

GettyImages-1341853306-logistics-network-globe-data-information

Individuals who spend time around clinical trial sponsors are likely to hear the words “real-world data” discussed as a kind of cure-all for creating more efficient trials. While real-world data has shown tremendous potential since it was first cleared for use by the FDA in 2016 through the Cures Act, its role in trials today often remains more aspirational than actual. If real-world data is really so effective, why aren’t more contract research organizations (CROs) using it? The problem stems in part from the fact that real-world data can mean a lot of different things, not all of which are well-suited to clinical trials depending on their scope and objective.

VIEW THE ARTICLE!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader